This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Sep 27;7(11):630.

doi: 10.1038/nrendo.2011.167.

Diabetes: T2DM-PPARγ ligands without the adverse effects?

PMID: 21946892
DOI: 10.1038/nrendo.2011.167

Comment

Diabetes: T2DM-PPARγ ligands without the adverse effects?

Carol Wilson. Nat Rev Endocrinol. 2011.

. 2011 Sep 27;7(11):630.

doi: 10.1038/nrendo.2011.167.

Author

PMID: 21946892
DOI: 10.1038/nrendo.2011.167

No abstract available

PubMed Disclaimer

Comment on

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.
Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y, He Y, Bruning JB, Marciano DP, Cameron MD, Laznik D, Jurczak MJ, Schürer SC, Vidović D, Shulman GI, Spiegelman BM, Griffin PR. Choi JH, et al. Nature. 2011 Sep 4;477(7365):477-81. doi: 10.1038/nature10383. Nature. 2011. PMID: 21892191 Free PMC article.

References

1. Nature. 2011 Sep 04;477(7365):477-81 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.